Zeliha Erkaya Turan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zeliha Erkaya Turan has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Aysu Şen
Necmettin Erbakan University, Faculty of Medicine, Department of Physiology, Konya, Türkiye
1 shared publication - Canan Eroğlu Güneş
Department of Medical Biology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey
1 shared publication - Ercan Kurar
Department of Medical Biology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey
1 shared publication - Fatma Bedia Karakaya Cimen
Yalova Üniversitesi
1 shared publication - Kaniye Zeynep Caliskan Sak
KTO Karatay University, Faculty of Medicine, Department of Physiology
1 shared publication - Selim Kutlu
Necmettin Erbakan University, Faculty of Medicine, Department of Physiology, Konya, Türkiye
1 shared publication
Latest Publications
- Open Access
- 31 January 2025
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 6 (1) , 1-7
Mu Opioid Agonistic Effect on Neuropeptide Gene Expression Levels Involved in Hypothalamic Feeding Regulation
Background: The regulation of food intake in the hypothalamus is one of most complicated through the integration of various neuroendocrine mechanisms. In this region, orexigenic and anorexigenic peptides play a role by responding to different stimuli. Additionally, central opioidergic systems are involved in the regulation of feeding behavior. Several neuropeptides expressed in the hypothalamus also contribute to the regulation of food intake. The aim of this study was to investigate the effects of mu opioidergic agonist/antagonist molecules on both orexigenic and anorexigenic peptides gene expression levels in the hypothalamus. Methods: In our study, 48 male Wistar Albino rats were divided into 4 groups as control, morphine, naloxone and morphine+naloxone. The control group received subcutaneous SF solution for 5 days; morphine group received morphine at a dose of 10 mg/kg/day for 5 days; naloxone group SF was administered for 5 days and naloxone at a dose of 3 mg/kg 1.5 hours after the last injection: morphine+naloxone group received naloxone 1.5 hours after 5 days of morphine injection. Hypothalamus tissues were isolated from brains at the end of experimental period. Anorexigenic and orexigenic peptide expression levels were analysed by RT-PCR method. Differences between groups were statistically analyzed using one-way factorial ANOVA and Tukey post-hoc test. Results: Morphine administration results in a decrease in the expression levels of OX2R and LepR genes, but did not change ORXA, OX1R, AgRP, NPY, POMC gene expression. Naloxone administration increased AgRP and NPY expression while decreasing OX2R, LepR and APLNR gene expression levels. Conclusions: Our findings suggest that morphine may affect the gene expression of molecules related to regulation of nutrition and metabolism in the hypothalamus. Further studies are needed to clarify the possible mechanistic effects of mu opiodergic activity on the central control of feeding in morphine dependence manner.
- 31 January 2025
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 6 (1) , 1-7
Open AccessMu Opioid Agonistic Effect on Neuropeptide Gene Expression Levels Involved in Hypothalamic Feeding Regulation
Background: The regulation of food intake in the hypothalamus is one of most complicated through the integration of various neuroendocrine mechanisms. In this region, orexigenic and anorexigenic peptides play a role by responding to different stimuli. Additionally, central opioidergic systems are involved in the regulation of feeding behavior. Several neuropeptides expressed in the hypothalamus also contribute to the regulation of food intake. The aim of this study was to investigate the effects of mu opioidergic agonist/antagonist molecules on both orexigenic and anorexigenic peptides gene expression levels in the hypothalamus. Methods: In our study, 48 male Wistar Albino rats were divided into 4 groups as control, morphine, naloxone and morphine+naloxone. The control group received subcutaneous SF solution for 5 days; morphine group received morphine at a dose of 10 mg/kg/day for 5 days; naloxone group SF was administered for 5 days and naloxone at a dose of 3 mg/kg 1.5 hours after the last injection: morphine+naloxone group received naloxone 1.5 hours after 5 days of morphine injection. Hypothalamus tissues were isolated from brains at the end of experimental period. Anorexigenic and orexigenic peptide expression levels were analysed by RT-PCR method. Differences between groups were statistically analyzed using one-way factorial ANOVA and Tukey post-hoc test. Results: Morphine administration results in a decrease in the expression levels of OX2R and LepR genes, but did not change ORXA, OX1R, AgRP, NPY, POMC gene expression. Naloxone administration increased AgRP and NPY expression while decreasing OX2R, LepR and APLNR gene expression levels. Conclusions: Our findings suggest that morphine may affect the gene expression of molecules related to regulation of nutrition and metabolism in the hypothalamus. Further studies are needed to clarify the possible mechanistic effects of mu opiodergic activity on the central control of feeding in morphine dependence manner.